Traws Pharma, Inc.
35 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model (NCT07503405) | Traws Pharma, Inc. | 2026-06-01 |
| This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza (NCT07371650) | Traws Pharma, Inc. | 2025-12-15 |
| Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19 (NCT07157007) | Traws Pharma, Inc. | 2025-09-16 |
| Evaluation Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of 83-0060 in Healthy Volunteers (NCT06402136) | Traws Pharma, Inc. | 2024-04-15 |
| Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies (NCT05705505) | Traws Pharma, Inc. | 2023-03-29 |
| Study of ON 123300 in Patients With Advanced Cancer (NCT04739293) | Traws Pharma, Inc. | 2021-05-13 |
Track Traws Pharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.